Summit Therapeutics Inc.
SMMT
$16.18
$0.060.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -219.17M | -231.79M | -565.71M | -62.91M | -61.20M |
| Total Depreciation and Amortization | 42.00K | 42.00K | 37.00K | 25.00K | 22.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 108.86M | 130.81M | 477.52M | 7.91M | 13.19M |
| Change in Net Operating Assets | 8.34M | 7.86M | 21.41M | -6.19M | -686.00K |
| Cash from Operations | -101.94M | -93.08M | -66.74M | -61.17M | -48.67M |
| Capital Expenditure | -164.00K | -71.00K | 0.00 | -422.00K | -14.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -484.99M | 0.00 | 150.81M | 160.53M | 83.50M |
| Cash from Investing | -485.16M | -71.00K | 150.81M | 160.11M | 83.48M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -24.50M |
| Issuance of Common Stock | 573.82M | 33.81M | 2.22M | 7.68M | 888.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 573.82M | 33.81M | 2.22M | 7.68M | -23.61M |
| Foreign Exchange rate Adjustments | -19.00K | 22.00K | 61.00K | 38.00K | -108.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.29M | -59.32M | 86.35M | 106.66M | 11.09M |